SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Researchers from VistaGen Therapeutics, together with Dr. Gordon Keller and his team of scientists from Toronto’s McEwen Centre for Regenerative Medicine and the Mount Sinai School of Medicine, have successfully identified key biochemical pathways involved in directing embryonic stem (ES) cells to become heart cells.
